Morgan Stanley Reaffirms Their Hold Rating on Iluka Resources Limited (ILKAF)
Morgan Stanley Maintains Overweight on Citizens Financial Group, Lowers Price Target to $31
Morgan Stanley: Sustained Industry-Leading Growth and Prospects Despite Lower EPS and NII – A Buy Recommendation
Argus Cuts Price Target on Morgan Stanley to $95 From $104, Maintains Buy Rating
BMO Capital Trims Price Target on Morgan Stanley to $101 From $102, Maintains Outperform Rating
Morgan Stanley Analyst Ratings
Morgan Stanley Adjusts Abbott Laboratories Price Target to $107 From $112, Maintains Equal Weight Rating
Morgan Stanley Trims Price Target on Tesla to $380 From $400, Notes Lower Auto Valuation, Keeps Overweight Rating
Long-Term Growth Potential Bolsters Buy Rating for Morgan Stanley Despite Short-Term Challenges
Morgan Stanley Downgrades Dada Nexus to Equal-Weight, Lowers Price Target to $4.78
Morgan Stanley: A Mixed Performance in 3Q23 Earnings – Hold Rating Justified
Morgan Stanley Cuts Lockheed Martin Price Target to $510 From $532, Maintains Equal Weight Rating
DBS Sticks to Their Buy Rating for Morgan Stanley (MS)
Morgan Stanley Remains a Buy on NOV (NOV)
International Business Machines (IBM) Gets a Hold From Morgan Stanley
Morgan Stanley Maintains Overweight on Diamondback Energy, Lowers Price Target to $169
Morgan Stanley Adjusts Devon Energy Price Target to $50 From $51, Maintains Equal Weight Rating
Morgan Stanley Cuts Price Target on International Business Machines to $130 From $135, Notes 'More Elevated' Risk of Q4 Consulting Slowdown; Equalweight Kept
Morgan Stanley Upgrades Array Technologies to Equal-Weight, Raises Price Target to $23
Morgan Stanley Upgrades Nabors Industries to Overweight, Raises Price Target to $175